Skip to main content
. 2018 May 18;144(8):1503–1507. doi: 10.1007/s00432-018-2666-9

Fig. 1.

Fig. 1

Treatment algorithm for pancreatic ductal adenocarcinoma (PDAC) patients. BRCA1 or 2 mutation determines the optimal therapy